Literature DB >> 8794021

DNA vaccines.

J B Ulmer1, J C Sadoff, M A Liu.   

Abstract

Preclinical DNA vaccine development has continued apace during the past year, with the investigation of several new infectious and non-infectious disease targets as well as advances in our understanding of some of the basic immunologic mechanisms, such as effector cells, responsible for conferring protection. The coming year promises to be at least as exciting, as initial human clinical studies have begun.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8794021     DOI： 10.1016/s0952-7915(96)80042-2

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN： 0952-7915            Impact factor:   7.486


  42 in total

Review 1.  Dendritic cell delivery of plasmid DNA. Applications for controlled genetic immunization.

Authors:  R J Mumper; H C Ledebur
Journal:  Mol Biotechnol       Date:  2001-09       Impact factor: 2.695

2.  C-C chemokine-encoding DNA vaccines enhance breakdown of tolerance to their gene products and treat ongoing adjuvant arthritis.

Authors:  S Youssef; G Maor; G Wildbaum; N Grabie; A Gour-Lavie; N Karin
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

3.  Plasmid DNA encoding replicating foot-and-mouth disease virus genomes induces antiviral immune responses in swine.

Authors:  G Ward; E Rieder; P W Mason
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

4.  Immuno-stimulatory effects of bacterial-derived plasmids depend on the nature of the antigen in intramuscular DNA inoculations.

Authors:  S W Lee; Y C Sung
Journal:  Immunology       Date:  1998-07       Impact factor: 7.397

5.  A physical map of the Leishmania major Friedlin genome.

Authors:  A C Ivens; S M Lewis; A Bagherzadeh; L Zhang; H M Chan; D F Smith
Journal:  Genome Res       Date:  1998-02       Impact factor: 9.043

6.  DNA immunization of neonates induces immunity despite the presence of maternal antibody.

Authors:  E Manickan; Z Yu; B T Rouse
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

7.  Recombinant parvovirus-like particles as an antigen carrier: a novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxic T cells.

Authors:  C Sedlik; M Saron; J Sarraseca; I Casal; C Leclerc
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

8.  Naked DNA vaccines expressing the prM and E genes of Russian spring summer encephalitis virus and Central European encephalitis virus protect mice from homologous and heterologous challenge.

Authors:  C Schmaljohn; L Vanderzanden; M Bray; D Custer; B Meyer; D Li; C Rossi; D Fuller; J Fuller; J Haynes; J Huggins
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

9.  Modulation of viral immunoinflammatory responses with cytokine DNA administered by different routes.

Authors:  S Chun; M Daheshia; N A Kuklin; B T Rouse
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

10.  Immunization of woodchucks with plasmids expressing woodchuck hepatitis virus (WHV) core antigen and surface antigen suppresses WHV infection.

Authors:  M Lu; G Hilken; J Kruppenbacher; T Kemper; R Schirmbeck; J Reimann; M Roggendorf
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.